MY ACCOUNT | NEWSLETTER |

Subchondral lucencies of the medial femoral condyle in yearling, two-year-old Thoroughbred sales horses


Background: Subchondral lucencies (SCLs) in the distal aspect of the medial femoral condyle (MFC) of young Thoroughbred horses are a source of controversy on presale radiographs. There is limited scientific evidence regarding the risk of progression and impact on future racing performance. 

Objectives: To identify the prevalence of MFC SCLs on sales repository radiographs in yearling and 2-year-old Thoroughbreds and identify any association between grade of MFC SCL and future racing performance and (3) monitor changes in MFC SCL grades between yearling and two-year-old sales. 

Study design: Prospective cohort study. 

Methods: Radiographs were obtained with consignor permission from a 2016 yearling sale and five 2017 2-year-old sales. Stifle radiographs were evaluated and MFC SCLs graded on a scale of 0-3. Axial MFC lucencies were recorded separately. Maximum MFC grades per horse were analyzed for associations with racing performance outcomes, adjusted for sex, to the end of the horses' 4-year-old racing year. Analysis was via logistic, negative binomial or linear regression as appropriate, with the threshold for significance set at α = 0.05. 

Results: Radiographs from 2508 yearlings (5016 stifles) and 436 2-year-olds (872 stifles) were included in the study. MFC SCLs of grades 1-3 were observed in 242 (9.65%) yearlings and 49 (11.2%) 2-year-olds. Bilateral MFC SCLs of grades 1-3 were observed in 54 (2.2%) yearlings and 12 (2.8%) 2-year-olds. Grade 1 MFC SCLs in yearlings either remained unchanged (14/31), progressed to a grade 2 (6/31) or resolved (11/31) by the 2-year-old sale. Grade 2 MFC SCLs in yearlings remained unchanged (6/10), progressed to a grade 3 (2/10) or improved to a grade 1 (2/10). Yearlings with a grade 3 MFC SCL had a 78% probability of starting a race (95% confidence interval [CI] 58.2-89.6%), compared with an 84% probability of racing for grade 0 yearlings (95% CI 82.7-85.8%). Six of the seven yearlings with axial MFC lucencies raced. 

Main limitations: This study may underestimate the prevalence of severe lesions in the general yearling population of U.S. Thoroughbreds. However, the convenience sample used is representative of the population of interest at sales. The study design could not address exclusions prior to sale. 

Conclusions: Grade 1 MFC SCLs are the most common type seen in yearling and 2-year-old sales horses. The majority of yearling grade 1 MFC SCLs resolved or remained static by two-year-old sales. It was also possible for grade 2 and 3 MFC SCLs to improve one grade between sales. Fewer sales yearlings with a grade 3 MFC SCL raced, but in those that did race there was no evidence of worse performance compared to unaffected peers. Axial MFC lucencies did not affect racing performance. 

Frances J Peat, Christopher E Kawcak, C Wayne McIlwraith, David P Keenan, Jeffrey T Berk, Daniel S Mork. "Subchondral lucencies of the medial femoral condyle in yearling and 2-year-old Thoroughbred sales horses: Prevalence, progression and associations with racing performance." 22 June 2023. Equine Veterinary Journal.  https://doi.org/10.1111/evj.13945


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Feline asthma: diagnosis and treatment

Like0
Dislike0

Treatment in canine epilepsy–a systematic review

Like0
Dislike0

Potential applications for antiviral therapy and prophylaxis in bovine medicine

Like0
Dislike0

The future of veterinary care

Like0
Dislike0

Olympic Champion Tara Lipinski Partners with Dutch to Raise Awareness of the Pet Care Gap Affecting 75 Million Americans

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top